Files

Marin_et_al_Oncoimmunology_2022.pdf (481.92 KB)

Document type

Article

Version

Published version

Publication date

2022-12-15

Publication license

cc by-nc (c) Marin, Ines et al., 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192013

Cellular senescence enhances adaptive anticancer immunosurveillance

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1080/2162402X.2022.2154115

Abstract

Cancer therapy often induces senescence in some cancer cells. Senescent cells, due to their profoundly altered biology, may conceivably interact with the adaptive immune system in novel ways that may boost cancer immunosurveillance, triggering the clearance of both senescent and non-senescent neoplastic cells. In this regard, we have recently reported that senescent cancer cells exhibit potent antigenicity and adjuvanticity and can elicit strong CD8(+) T cell-dependent anticancer effects when used as vaccination agents.

Subject

Envelliment, Inflamació, Interferó, Vacunació

Subject (English)

Aging, Inflammation, Interferon, Vaccination

Citation

Collections

Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))

Citation

MARIN, Ines, SERRANO MARUGÁN, Manuel and PIETROCOLA, Federico. Cellular senescence enhances adaptive anticancer immunosurveillance. OncoImmunology. 2023. Vol. 12, num. 1, pags. 2154115. ISSN 2162-402X. [consulted: 7 of June of 2026]. Available at: https://hdl.handle.net/2445/192013

Export metadata

JSON - METS

Share record